Sebastian Jugl, B.S.Pharm, R.Ph.

Sebastian jugl

Contact Information

Curriculum Vitae


  • 2013 – 2017 B.S.Pharmacy: Goethe-Universität Frankfurt am Main
  • 2017 – 2018 Pre-registration year for pharmacists
  • 2019 R.Ph.: – State board examination

Entry Date into the POP Ph.D. program:  Fall, 2019

Research Interests

  • Research interests include applying pharmacoepidemiologic methods to investigate drug utilization, drug safety, and the effects of state and federal laws in the area of oncology, women’s health, and medical cannabis research

Professional Experience

  • 01/2019 – 07/2019: (Chief) locum pharmacist in hospital and community pharmacies in Germany, “Belu Industrie Service GmbH”
  • Since 07/2018: Author for “DPhG” (German Pharmaceutical Society) and “Avoxa – Mediengruppe Deutscher Apotheker GmbH”
  • 07/2018 – 11/2018: Consultant for drug therapy safety and medication management at “Dr. Walter’s Markt-Apotheke”
  • 05/2018 – 10/2018: Research Intern, University of Florida, College of Pharmacy, Department for Pharmaceutical Outcomes & Policy (pre-registration year)
  • 10/2017 – 04/2018: Pharmacist intern, “Dr. Walter’s Markt-Apotheke”, Germany, (pre-registration year)


  • 08/2021 Scholarship, 37th International Conference on Pharmacoepi-demiology and Therapeutic Risk Management (ICPE) All Access (virtual conference)
  • 09/2020 Scholarship, 36th International Conference on Pharmacoepi-demiology and Therapeutic Risk Management (ICPE) All Access (virtual conference)
  • 08/2019 – 08/2022 Grinter Fellowship, University of Florida, College of Pharmacy, Department of Pharmaceutical Outcomes & Policy
  • 05/2018 – 10/2018 Scholarship holder from “Deutsche Gesellschaft für Internationale Zusammenarbeit (GiZ)” for the research internship at the University of Florida
  • 10/2015 – 10/2017 Scholarship recipient of the “Deutschlandstipendium” at the Goethe University, Frankfurt am Main


  1. Sajdeya R, Shavers A, Jean-Jacques J, Costales B, Jugl S, Crump C, Wang Y, Manfio L, Pipitone R N, Rosenthal M S, Winterstein A G, Cook R L. Practice Patterns and Training Needs Among Physicians Certifying Patients for Medical Marijuana in Florida. Journal of Primary Care & Community Health, Vol 12, January 2021. doi:10.1177/21501327211042790
  2. Sarayani A, Jugl S, Winterstein AG. Letter by Sarayani et al Regarding Article, “Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque”. Circulation, Vol 143(25), June 2021, pp. e1031-1032.
  3. Jugl S, Sajdeya R, Morris E, Goodin A, Brown JD: Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit. Medical Cannabis and Cannabinoids, June 2021.
  4. Jugl S. Therapeutische Leitlinien in der pharmazeutischen Praxis: Endometriose. PHARMAKON, Vol 9, May 2021, Supplement 2, pp.1-8(8) [German]
  5. Jugl S, Okpeku A, Costales B, Morris E, J, Alipour-Haris G, Hincapie-Castillo J, M, Stetten N, E, Sajdeya R, Keshwani S, Joseph V, Zhang Y, Shen Y, Adkins L, Winterstein A, G, Goodin A: A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Medical Cannabis and Cannabinoids 2021. doi: 10.1159/000515069